Synthesis and Anticancer Evaluation of O-Alkylated (E)-Chalcone Derivatives: A Focus on Estrogen Receptor Inhibition
Open Access
- 20 January 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 833
Abstract
Cancer remains a leading cause of morbidity and mortality worldwide, highlighting the urgent need for novel therapeutic agents. This study investigated the synthesis and biological evaluation of O-alkyl (E)-chalcone derivatives (4a–4v) as potential anticancer agents. The compounds were synthesized via aldol condensation of substituted aldehydes and acetophenones, with structures confirmed by IR, NMR, and mass spectrometry. In vitro cytotoxicity assays revealed varying effectiveness, with compounds 4a, 4b, 4q, and 4v exhibiting potent activity against MDA-MB-231 and MCF-7, showing IC50 values between 2.08 and 13.58 µM, besides HCT-116 and HeLa cancer cell lines (IC50 values between 6.59 and 22.64 µM). Notably, compound 4b displayed remarkable selectivity, with an IC50 of 54.59 µM against the non-cancerous WI-38 cell line. Additionally, protein kinase inhibition assays indicated that compounds 4b and 4q effectively inhibited EGFR and VEGFR-2, with 4b outperforming the standard inhibitor erlotinib. Molecular docking studies of compound 4q showed strong binding affinities in the ATP-binding pockets of EGFR, HER2, VEGFR2, and CDK2. In silico analyses further highlighted the favorable pharmacokinetic properties of compound 4q, underscoring its potential as a selective tyrosine kinase inhibitor. These findings suggest the therapeutic promise of O-alkyl (E)-chalcone derivatives in cancer treatment.Keywords
Funding Information
- King Saud University, Riyadh, Saudi Arabia (RSP2025R207)
This publication has 73 references indexed in Scilit:
- Synthesis, Docking Studies and Evaluation of Chalcones as Anti‐Helicobacter pylori and antitumoral AgentsChemistry & Biodiversity, 2023
- In silico screening of alkaloids as potential inhibitors of HER2 protein for breast cancer treatmentVietnam Journal of Chemistry, 2023
- Synthesis of lithium/cesium-Zagronas from zagrosian natural asphalt and study of their activity as novel, green, heterogeneous and homogeneous nanocatalysts in the Claisen–Schmidt and Knoevenagel condensationsJournal of the Iranian Chemical Society, 2021
- Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and DifferencesDrugs, 2020
- Proapoptotic and anti-angiogenic activity of (2E)-3-(2-bromo-6-hydroxy-4-methoxyphenyl)-1-(naphthalene-2-yl) prop-2-en-1-one in MCF7 cell lineChemical Papers, 2020
- Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open QuestionsDiscover Oncology, 2019
- Breast Cancer TreatmentJAMA, 2019
- The in vivo estrogenic and in vitro anti‐estrogenic activity of permethrin and bifenthrinEnvironmental Toxicology and Chemistry, 2012
- Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanismsInternational Journal of Cancer, 2010
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009